China’s new trade offer is better than a tariff

New Post Public Reply Private Reply Replies (0) Message Board
wowhappens28
212
China’s new trade offer is better than a tariff war

https://www.ft.com/content/b64a5c44-3034-11e9...016697f225


Please use the sharing tools found via the share button at the top or side of articles. Copying articles to share with others is a breach of FT.com T&Cs and Copyright Policy. Email licensing@ft.com to buy additional rights. Subscribers may share up to 10 or 20 articles per month using the gift article service. More information can be found at https://www.ft.com/tour.
https://www.ft.com/content/b64a5c44-3034-11e9...016697f225

Although investors have become increasingly optimistic about the US-China trade negotiations, there are many “structural issues” concerning the Chinese economic model still to be solved.

Recent reports suggest that China has made a dramatic proposal to address the central issue of imbalanced trade. This would eliminate entirely its bilateral trade surplus with America within six years. Since this surplus reached $380bn in 2018 on trade in goods and services, and may exceed $500bn by 2024, this idea could have a large effect on global trade flows and world gross domestic product.

Noah Smith dismisses this new Chinese suggestion as a massive red herring because its implementation would clash with other objectives of President Xi Jinping’s administration. But it is clearly at the centre of the latest talks so it deserves analysis.

The basic idea is that China would directly stimulate purchases of American goods, closing the bilateral trade imbalance without the need for US tariffs on imports from China.

At the extreme, China would boost its American imports by the entire $500bn while leaving its trading flows with the rest of the world unchanged. Even a smaller version of this plan would be significant.

In theory, this looks like an attractive idea, since it would involve an increase in global demand if China financed the purchases by fiscal or monetary expansion. Economists have typically argued for such expenditure-increasing initiatives by other countries with chronic trade surpluses, such as Germany and Japan. 

In simple national accounting terms, China would reduce its overall savings ratio by boosting domestic demand, say through fiscal expansion. Imports to China would rise by the same amount, leaving Chinese GDP unchanged. 

In the US, there would be a rise in exports and GDP. Assuming a multiplier of 1.5, the level of US GDP could rise by 2.5-3 per cent when the plan is fully implemented over six years. 

This would be less damaging for the global economy than a war of escalating tariffs, which would increase inflation, reduce real demand and disrupt supply chains.

However, this assumes that the extra US exports to China are genuinely incremental and are not just diverted from other markets. It also assumes that the US economy has enough spare capacity to produce these extra exports without causing inflation, tighter US monetary policy and a rising dollar.

If these caveats fail to hold, as would probably be the case in the real world, the benefits to the US economy would be much smaller.


Please use the sharing tools found via the share button at the top or side of articles. Copying articles to share with others is a breach of FT.com T&Cs and Copyright Policy. Email licensing@ft.com to buy additional rights. Subscribers may share up to 10 or 20 articles per month using the gift article service. More information can be found at https://www.ft.com/tour.
https://www.ft.com/content/b64a5c44-3034-11e9...016697f225

The plan would increase US exports to China by at least threefold. This looks implausibly large. Furthermore, these additional US exports would come partly from high technology sectors, triggering even greater American complaints about forced technology transfers to China.

The plan could also create collateral financial problems. If China directly increases imports from the US by about $500bn, the initial effect would be to worsen its global current account balance by the same amount. 

In an earlier era, when China was running a huge current account surplus, that would have been considered a good outcome. But that era has changed. China’s current account was almost exactly in balance in 2018, so the change in the bilateral position versus the US, all else equal, could take China into an overall current account deficit of about half a trillion dollars, 

Why would this cause a problem? One issue is that, at times, China also runs a very large deficit on net capital flows. For example, from mid-2014 to early 2017, when the capital account was liberalised and the renminbi was expected to depreciate, net private capital outflows exceeded $1tn. These outflows have now diminished, but could return, if in smaller scale.

This means that, under the new plan, the current account plus private capital account outflows could shift into heavy deficit, implying that other capital inflows will be needed to balance the books. China is aiming to deepen and open its domestic financial markets, attracting inflows of long-term portfolio flows from the advanced economies. But it will take a long time to create enough financial capacity in China to handle the scale of the necessary inflows.

A structural deficit in China’s balance of payments (ex official flows) could therefore lead to downward pressure on the renminbi, exporting deflationary pressures to other economies, and causing American complaints about currency manipulation.

As a last resort, China could support its currency by running down its foreign exchange reserves, which are still more than $3tn. But this would involve selling their holdings of US Treasuries, adding to recent market concerns about the effects of quantitative tightening by the Federal Reserve. All this could cause global financial instability.

In order to avoid some of these problems, China could adopt a different approach, which would be to increase imports from the US by substituting them for goods currently purchased from other economies. Switching energy purchases towards the US would, for example, seem relatively straightforward. 

In principle, China might also raise tariffs on items such as German manufactured goods and Brazilian soyabeans, while eliminating tariffs on American goods. However, such a wholesale repudiation of multilateral World Trade Organization principles would cause a new set of losers and almost certainly tariff retaliations from the likes of the eurozone and Japan. 

Conclusion
Although fraught with difficulties, a new trade agreement to restore peace between the US and China by focusing on higher US exports as the main vehicle to close the bilateral imbalance would probably be better than a tariff war, for both global demand and supply chains.

But the negotiators are stuck in a “second best” world. An export purchase plan would be hard to implement and could create problems elsewhere in the global trade and financial system. A rising dollar could undermine the whole plan.

The “first best” system would involve global free trade and flexible exchange rates on a multilateral basis. But that does not appear to be on the agenda, while President “I happen to like tariffs” Trump remains at the helm. 
Scroll down for more posts ▼

Top 10 Most Recent News Articles

OncoHost's Research Links TKI Sensitivity to Biology

Updated Category News Views 121

Cracking the Code on TKI Sensitivity When it comes to medicine, sometimes the trickiest part is knowing which button to push—especially in the high-stakes world of metastatic renal cell carcinoma (mRCC). OncoHost just dropped a bombshell at the ESMO 2026 Congress about their new plasma proteomics model that lets us peer into what makes some patients click with Tyrosine...

Continue Reading
Honeywell Aerospace Faces Lawsuit After Stock Tumbles 23%

Updated Category News Views 84

Honeywell's Bumpy Ride Rattles Investors Something's brewing over at Honeywell Aerospace, Inc. (NASDAQ:HONA) and it's not your regular cup of joe. Investors, brace yourselves, because a securities fraud class action lawsuit is stacking up against them. With shares plummeting 23.16% in a whirlwind of a market day, it's kind of hard not to get a little riled up, isn't it?...

Continue Reading
HCLTech Partners with Rapidus on Semiconductor Future

Updated Category News Views 116

Making Sense of the HCLTech and Rapidus Collaboration When you're talking about the world of semiconductors, no two words get tossed around more than innovation and speed. Now, with the recent partnership between HCLTech and Rapidus, those words are bound to echo from India to Japan and beyond. We have HCLTech, a stalwart of global technology, teaming up with Rapidus, a...

Continue Reading
Marc Jacobs Expansion: Bold Moves, Bigger Markets

Updated Category News Views 32

Marc Jacobs' Bold Move into Greater China There's a new gust blowing through the retail fashion industry, and it's coming from the partnership between WHP Global, G-III Apparel Group, and I.T Group. These seasoned players are betting big on Marc Jacobs to expand its footprint in the Greater China region. I can practically see the dollar signs in their eyes as they dive...

Continue Reading
Thanksgiving Relief: Alabama Firm Offers $200 Gift Cards

Updated Category News Views 101

A Firm's Gratitude with a Dash of Holiday Cheer It takes more than just legal prowess to make waves in a community. Tyler Mann Injury Law is stepping outside the courtroom to bring some warmth to Alabama families this Thanksgiving. They're hosting a giveaway that puts a little financial relief where it counts—at the Thanksgiving dinner table, straightening out the...

Continue Reading
Medline's Decade-Long WRAP Partnership: More Than Labels

Updated Category News Views 144

A Decade of Trust and Responsibility Here we go, folks—Medline is toasting 10 years with WRAP, and this ain't just fluffy PR spin. When two big players like these lock arms over responsible manufacturing, it's a signal worth paying attention to, and not just for the ethics alone. Production practices that prioritize transparency and worker rights have ramifications...

Continue Reading
Workers at CertainTeed Plant Unionize with Teamsters

Updated Category News Views 112

Unity at CertainTeed Sends Ripples through Industry Here's something that'll stir your coffee: 170 workers at CertainTeed's fiberglass facility in Chowchilla, California, just decided they won't take management's antics lying down. These folks voted to join Teamsters Local 431, aiming for some long-overdue respect and a contract that'll guarantee better wages and...

Continue Reading
Landis+Gyr's Big Contract Victory: A Game Changer?

Updated Category News Views 0

Diving into Landis+Gyr's Major Utility Win When news hits about a deal secured by Landis+Gyr Group AG, it rings a few bells across the utility landscape. These folks have brewed up a storm with a fresh contract that slots into their rapidly expanding portfolio of grid-savvy products. So, what’s the fuss about this latest agreement? A Groundbreaking Contract Now, this...

Continue Reading
Canton Fair: More Than Trade—A Cultural Exchange

Updated Category News Views 87

Why a Trade Fair Needs Lion Dances October 2026 marks a time when talking about a trade fair means diving headfirst into a whirlpool of global exchange and cultural tango we don’t often see in the West. Yeah, I'm looking at you, Canton Fair—a long-runner over in China that's managed to haul in the globe to not just showcase wares, but bring people together in a clash...

Continue Reading
Retlaw Industries Acquired by AIM Processing in Major Deal

Updated Category News Views 0

Retlaw's Big Move in the Plastics Game In the sprawling world of plastics, some might say each piece tells a story—not unlike this latest saga with Retlaw Industries, Inc. and AIM Processing. Picture Wisconsin's Retlaw, nestled in the heart of manufacturing, recently shaking hands with fellow molder AIM Processing. This isn't just a neighborly team-up; it's a power play...

Continue Reading

Top 5 Most Recently Viewed Articles

Fosun International's Steady Growth: A Look at 2025 Results

Updated Category News Views 224

Fosun International Reports Impressive Interim Results Fosun International Limited (HKEX stock code: 00656, "Fosun International") has announced robust interim results, highlighting sustained growth across its core businesses. The total revenue reached RMB87.28 billion, with notable strides in global operations and technological innovation. Key Financial Highlights The...

Continue Reading
Flare Therapeutics Shines Light on FX-909 Phase 1A Breakthrough

Updated Category News Views 159

Flare Therapeutics Presents Groundbreaking Phase 1A Results Flare Therapeutics Inc. has recently made headlines with their announcement regarding the presentation of clinical data for FX-909, a promising therapeutic candidate in the fight against cancer. This upcoming presentation will take place at an esteemed conference focusing on molecular targets and cancer...

Continue Reading
RIV Capital Expands Adult-Use Cannabis Sales in Kingston

Updated Category News Views 71

RIV Capital Expands Adult-Use Cannabis Sales in Kingston RIV Capital Inc. (CSE: RIV) is making strides in the cannabis market with its recent announcement regarding the launch of adult-use sales at the Etain dispensary. This development marks a significant milestone in the company’s efforts to provide both medical and recreational cannabis to consumers. Location and...

Continue Reading
Water.org's Innovative Strategies for Fighting Water Scarcity

Updated Category News Views 336

Water.org's Commitment to Addressing Water Issues Water.org is embarking on an ambitious journey in FY25, focusing on crucial strategies to tackle the world's water and sanitation crisis. Building on substantial accomplishments from FY24, the organization mobilized $965 million to provide safe water and sanitation to over 10.2 million people. Their relentless efforts to...

Continue Reading
Dexcom's Promising Revenue Projections for 2025 Ignite Interest

Updated Category News Views 484

Dexcom's Positive Revenue Outlook Shares of Dexcom (NASDAQ: DXCM), a leading company in medical devices focused on glucose monitoring systems, have experienced a notable uptick of 5%. This surge in stock value comes on the heels of their announcement regarding the anticipated revenue for 2025. Strong Fourth-Quarter Performance In an encouraging sign for investors,...

Continue Reading